Synergistic Antitumor Interaction of Risedronate Sodium and Standard Anticancer Agents in Canine (D-17) and Human Osteosarcoma (U-2 OS) Cell Lines

SIMPLE SUMMARY: The study investigated canine (D-17) and human (U-2 OS) osteosarcoma exposition to risedronate sodium and chosen standard anticancer drugs concurrently used in vitro. Risedronate sodium is frequently used in the therapy of bone tissue disorders. Our study demonstrated increased effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Poradowski, Dominik, Chrószcz, Aleksander, Obmińska-Mrukowicz, Bożena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996979/
https://www.ncbi.nlm.nih.gov/pubmed/35405855
http://dx.doi.org/10.3390/ani12070866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996979/
https://www.ncbi.nlm.nih.gov/pubmed/35405855
http://dx.doi.org/10.3390/ani12070866

Ejemplares similares